At what degree of hypotension or bradycardia should a dose of propranolol be withheld?

When to Withhold Propranolol: Blood Pressure and Heart Rate Thresholds

Withhold propranolol when systolic blood pressure is less than 90-100 mmHg or heart rate is less than 50 beats per minute. These are the most consistently cited thresholds across multiple ACC/AHA guidelines for acute cardiovascular settings 1, 2, 3, 2.

Specific Thresholds by Clinical Context

Acute Cardiovascular Settings (ACS, Perioperative)

The most robust guidance comes from ACC/AHA cardiovascular guidelines, which provide clear parameters:

Blood Pressure:

• Hold if systolic BP < 90-100 mmHg 1, 2, 3, 2
• In perioperative settings, the POISE trial held medication when systolic BP dropped below 100 mmHg 4, 5

Heart Rate:

• Hold if heart rate < 50 bpm 1, 2, 3, 2
• Some protocols specify holding for heart rate consistently below 45 bpm, with a 12-hour delay for rates of 45-49 bpm 4, 5

Supraventricular Tachycardia Management

For acute IV propranolol administration in SVT, the guidelines specify similar precautions 6:

• Avoid in patients with hypotension
• Avoid in decompensated heart failure
• Avoid with AV block greater than first degree or SA node dysfunction (without pacemaker)

Pediatric Use (Infantile Hemangiomas)

For chronic oral propranolol in infants, the thresholds are less stringent 7:

• Doses should be held during times of diminished oral intake or vomiting (to prevent hypoglycemia)
• No specific BP/HR thresholds are mandated for routine dosing
• Recent evidence suggests that in healthy full-term infants, propranolol 2 mg/kg/day is well-tolerated without clinically significant hypotension 8

Clinical Decision Algorithm

Before each dose, assess:

1. Systolic blood pressure:

   • If < 90 mmHg → Hold dose
   • If 90-100 mmHg → Use clinical judgment (consider holding in acute settings, may continue in stable chronic therapy)
   • If > 100 mmHg → Safe to administer

2. Heart rate:

   • If < 45 bpm → Hold dose
   • If 45-49 bpm → Delay 12 hours, reassess
   • If < 50 bpm in acute/perioperative settings → Hold dose
   • If ≥ 50 bpm → Safe to administer

3. Additional contraindications:

   • Evidence of low-output state (oliguria, altered mental status)
   • Sinus tachycardia reflecting low stroke volume (paradoxical indication to hold)
   • Signs of decompensated heart failure (rales, S3 gallop)
   • Active bronchospasm

Important Caveats

Context matters significantly: The 50 bpm threshold is most critical in acute cardiovascular settings and perioperative care 1, 2, 3, 2, 4, 5. For chronic stable therapy (e.g., migraine prophylaxis, stable angina), slightly lower heart rates may be tolerated if the patient is asymptomatic.

Hypotension and bradycardia are associated with worse outcomes: In the POISE trial, clinically significant hypotension was associated with an adjusted odds ratio for death and stroke of 4.97, while bradycardia had an OR of 2.13 4, 5. This underscores that these parameters are not arbitrary—they represent real risk thresholds.

Search for alternative causes: If a patient on chronic propranolol develops tachycardia, investigate for sepsis, hypovolemia, pulmonary embolism, or anemia before simply increasing the beta-blocker dose 4, 5. These conditions may warrant temporary discontinuation rather than dose escalation.

Pediatric considerations: In infants receiving propranolol for hemangiomas, the primary concern is hypoglycemia during illness rather than cardiovascular parameters 7. Hold doses during vomiting or poor oral intake regardless of vital signs.

Monitoring frequency: For acute initiation or IV administration, continuous ECG monitoring and frequent BP checks are essential 1, 2, 3, 2. However, for stable chronic therapy in healthy patients, prolonged vital sign monitoring has limited utility and does not predict future adverse events 9.